Biotts

📍 Bielany Wrocławskie, Poland🗓 Founded 2018👥 19 employees💰 Last funded May 2022
Pharmaceutical Manufacturing🌐 biotts.com
Website LinkedIn
BIOTTS, a Polish-American biotech company, develops proprietary drugs in oncology, diabetology and pain utilizing unique formulations and drug delivery technologies. Biotts scientists have developed a breakthrough technology of universal transdermal therapeutic system MTC-Y (Multifunctional Transdermal Carrier-Y). The properties of the carrier increase the bioavailability of active substances several times, enabling them to penetrate through the skin into soft tissues and bones. The carrier can be easily modified to obtain targeted action in pathologically changed tissues. Thanks to the system, it is possible to reduce the therapeutic dose of the drug while maintaining its original effect and simultaneously reducing the side effects. In addition, the system enables the transport of one to several active substances, which makes it possible to design multi-component drugs.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Poland
3
Investor activity2020–2022 · investors recorded per year
2020220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Biotts?
Biotts has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Biotts last raise funding?
The most recent investment in Biotts recorded on gritt.io was in May 2022.
When was Biotts founded?
Biotts was founded in 2018.
What industry is Biotts in?
Biotts operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Biotts based?
Biotts is headquartered in Bielany Wrocławskie, Poland.